168 related articles for article (PubMed ID: 17600594)
1. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a gp 55 (E2) recombinant-based ELISA for the detection of antibodies induced by classical swine fever virus.
Müller A; Depner KR; Liess B
Dtsch Tierarztl Wochenschr; 1996 Nov; 103(11):451-3. PubMed ID: 8968126
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus.
Piriou L; Chevallier S; Hutet E; Charley B; Le Potier MF; Albina E
Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856
[TBL] [Abstract][Full Text] [Related]
4. Candidate peptide vaccine induced protection against classical swine fever virus.
Dong XN; Wei K; Liu ZQ; Chen YH
Vaccine; 2002 Dec; 21(3-4):167-73. PubMed ID: 12450690
[TBL] [Abstract][Full Text] [Related]
5. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
[TBL] [Abstract][Full Text] [Related]
6. Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.
de Smit AJ
Vet Q; 2000 Oct; 22(4):182-8. PubMed ID: 11087126
[TBL] [Abstract][Full Text] [Related]
7. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge.
van Rijn PA; Bossers A; Wensvoort G; Moormann RJ
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2737-45. PubMed ID: 8922467
[TBL] [Abstract][Full Text] [Related]
8. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
Kaden V; Schurig U; Steyer H
Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
[TBL] [Abstract][Full Text] [Related]
10. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
[TBL] [Abstract][Full Text] [Related]
11. Assessment of safety and protective value of a cell culture modified strain "C" vaccine of hog cholera/classical swine fever virus.
Dahle J; Liess B
Berl Munch Tierarztl Wochenschr; 1995 Jan; 108(1):20-5. PubMed ID: 7779071
[TBL] [Abstract][Full Text] [Related]
12. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.
van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ
Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861
[TBL] [Abstract][Full Text] [Related]
13. Oral and sub-cutaneous vaccination of commercial pigs with a recombinant porcine adenovirus expressing the classical swine fever virus gp55 gene.
Hammond JM; Jansen ES; Morrissy CJ; Williamson MM; Hodgson AL; Johnson MA
Arch Virol; 2001; 146(9):1787-93. PubMed ID: 11699963
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
Bouma A; de Smit AJ; de Kluijver EP; Terpstra C; Moormann RJ
Vet Microbiol; 1999 Apr; 66(2):101-14. PubMed ID: 10227472
[TBL] [Abstract][Full Text] [Related]
15. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.
van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ
Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808
[TBL] [Abstract][Full Text] [Related]
16. Development of a competitive ELISA using a truncated E2 recombinant protein as antigen for detection of antibodies to classical swine fever virus.
Clavijo A; Lin M; Riva J; Mallory M; Lin F; Zhou EM
Res Vet Sci; 2001 Feb; 70(1):1-7. PubMed ID: 11170845
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows.
Ahrens U; Kaden V; Drexler C; Visser N
Vet Microbiol; 2000 Nov; 77(1-2):83-97. PubMed ID: 11042402
[TBL] [Abstract][Full Text] [Related]
18. Development of a classical swine fever subunit marker vaccine and companion diagnostic test.
Moormann RJ; Bouma A; Kramps JA; Terpstra C; De Smit HJ
Vet Microbiol; 2000 Apr; 73(2-3):209-19. PubMed ID: 10785329
[TBL] [Abstract][Full Text] [Related]
19. Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine.
de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
Vet Q; 2000 Jul; 22(3):150-3. PubMed ID: 10952445
[TBL] [Abstract][Full Text] [Related]
20. [Use of recombinant protein E2 of the classical swine fever virus for immunization of animals].
Tsibezov VV; Bogdanova VS; Zaberezhny AD; Grebennikova TV; Krivonos AV; Dudnikov LA; Kal'nov SL; Aliper TI; Nepoklonov EA
Vopr Virusol; 2000; 45(2):36-41. PubMed ID: 10765549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
